Skip to main content
. Author manuscript; available in PMC: 2009 Jan 1.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Apr 11;49(7):2878–2887. doi: 10.1167/iovs.07-1576

Figure 6.

Figure 6

Effect of Hsp90 ATPase inhibitor GA on AIPL1 chaperone activity. Graphs of the inclusion incidence for the effect of GA on the AIPL1-mediated suppression of (A) GFP-NUB1-N inclusions and (B) GFP-NUB1-C inclusions. The percentage of GFP-NUB1-N or GFP-NUB1-C inclusions alone (CON) or in the presence of AIPL1 (AIPL1) was assessed in the absence of treatment (no treatment, 0 hours) and after 4-hour treatment with vehicle or 5 μM GA. Error bars are ± SD. Unpaired Student’s t-test was used to determine levels of statistical significance.